For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Pneumatic Vitreolysis (PVL) | Pneumatic vitreolysis is an in-office intraocular injection of an expansile gas (C3F8) to induce release of vitreomacular traction. | 0 | None | 5 | 35 | 15 | 35 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Anterior chamber cell | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA (10.0) | View |
| Anterior chamber opacity | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA (10.0) | View |
| Cataract | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA (10.0) | View |
| Corneal abrasion | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA (10.0) | View |
| Corneal defect | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA (10.0) | View |
| Corneal edema | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA (10.0) | View |
| Corneal pigmentation | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA (10.0) | View |
| Dry eye | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA (10.0) | View |
| Eye irritation | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA (10.0) | View |
| Eye itching | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA (10.0) | View |
| Eye pain | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA (10.0) | View |
| Floaters | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA (10.0) | View |
| Macular hole | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA (10.0) | View |
| Ocular discomfort | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA (10.0) | View |
| Ocular hypertension | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA (10.0) | View |
| Posterior capsule opacification | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA (10.0) | View |
| Posterior vitreous detachment | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA (10.0) | View |
| Red eye | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA (10.0) | View |
| Subconjunctival hemorrhage | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA (10.0) | View |
| Visual acuity decreased | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA (10.0) | View |
| Visual flashes | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA (10.0) | View |
| Vitreous debris | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA (10.0) | View |
| Vitreous hemorrhage | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA (10.0) | View |